These immunosuppressive mechanisms affect tumor-infiltrating lymphocytes (TILs), including helper CD4+ T cells, cytotoxic CD8+ T cells, B cells and natural killer (NK) cells (20–22), and ultimately the effectiveness of immunomodulatory strategies. This evidence concerns the gene CD4 and neoplasm.